These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15897989)

  • 1. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.
    Heffernan RT; Barrett NL; Gallagher KM; Hadler JL; Harrison LH; Reingold AL; Khoshnood K; Holford TR; Schuchat A
    J Infect Dis; 2005 Jun; 191(12):2038-45. PubMed ID: 15897989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.
    Nuorti JP; Butler JC; Gelling L; Kool JL; Reingold AL; Vugia DJ
    Ann Intern Med; 2000 Feb; 132(3):182-90. PubMed ID: 10651598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization.
    Flannery B; Heffernan RT; Harrison LH; Ray SM; Reingold AL; Hadler J; Schaffner W; Lynfield R; Thomas AR; Li J; Campsmith M; Whitney CG; Schuchat A
    Ann Intern Med; 2006 Jan; 144(1):1-9. PubMed ID: 16389249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis.
    Nunes MC; von Gottberg A; de Gouveia L; Cohen C; Moore DP; Klugman KP; Madhi SA
    AIDS; 2011 Feb; 25(4):453-62. PubMed ID: 21178754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
    Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
    AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy.
    Harrison LH; Dwyer DM; Billmann L; Kolczak MS; Schuchat A
    Arch Intern Med; 2000 Jan; 160(1):89-94. PubMed ID: 10632309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program.
    Nunes MC; von Gottberg A; de Gouveia L; Cohen C; Kuwanda L; Karstaedt AS; Klugman KP; Madhi SA
    PLoS One; 2011; 6(11):e27929. PubMed ID: 22140487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
    Dworkin MS; Ward JW; Hanson DL; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Mar; 32(5):794-800. PubMed ID: 11229848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.
    Flannery B; Schrag S; Bennett NM; Lynfield R; Harrison LH; Reingold A; Cieslak PR; Hadler J; Farley MM; Facklam RR; Zell ER; Whitney CG;
    JAMA; 2004 May; 291(18):2197-203. PubMed ID: 15138241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of highly-active antiretroviral therapy by race/ethnicity.
    Silverberg MJ; Wegner SA; Milazzo MJ; McKaig RG; Williams CF; Agan BK; Armstrong AW; Gange SJ; Hawkes C; O'Connell RJ; Ahuja SK; Dolan MJ;
    AIDS; 2006 Jul; 20(11):1531-8. PubMed ID: 16847408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
    Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
    Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalizations for invasive pneumococcal disease among human immunodeficiency virus-1 infected children, adolescents and young adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine.
    Kourtis AP; Ellington S; Bansil P; Jamieson DJ; Posner SF
    Pediatr Infect Dis J; 2010 Jun; 29(6):561-3. PubMed ID: 20094005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.
    Fry AM; Facklam RR; Whitney CG; Plikaytis BD; Schuchat A
    J Infect Dis; 2003 Sep; 188(5):643-52. PubMed ID: 12934179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Spicer JO; Thomas S; Holst A; Baughman W; Farley MM
    Pediatr Infect Dis J; 2014 Feb; 33(2):158-64. PubMed ID: 24418837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
    Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A
    Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.